Self-testing for 5 respiratory viruses in adult VACCELERATE volunteers in Germany—a pilot study on multi-pathogen rapid antigen testing to monitor community-acquired acute respiratory infections
Frontiers in Public Health · 03.09.2025 · 13
DOI: 10.3389/fpubh.2025.1638280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 03.09.2025. Verfasst von Julia A Nacov und 16 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in …. Hauptthemen laut MEDLINE: Respiratory Tract Infections, Community-Acquired Infections, Self-Testing, Antigens, Viral. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acute respiratory infections (ARI) are the most common human infections. Diagnostic testing for respiratory pathogens is largely restricted to medical institutions. Self-testing may allow for real-time epidemiological monitoring of ARI pathogens, in particular in individuals not seeking medical attention.
Methods
Adults from the VACCELERATE Volunteer Registry received a test-kit for multiple respiratory antigens, a laminar flow device (LFD) detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza viruses A and B, respiratory syncytial virus (RSV) and adenovirus (ADV) from a single nasal swab. During one winter season, participants self-tested upon ARI symptoms, reported LFD result as well as symptoms, vaccination history, and any underlying conditions. Participants who remained without ARI symptoms self-tested on the last day of the study period.
Results
Between December 7, 2022, and June 2, 2023, 1,429 participants communicated their self-testing results. Of these 1,119 (78.3%) individuals had developed ARI symptoms and self-tested until May 31, 2023. Overall, 359 of 1,119 (32.1%) tests were positive with 17 (1.5%) co-detections, resulting in 377 detected pathogens overall. Thirteen tests (1.2%) were invalid or failed technically, and 747 (66.8%) were negative. The most frequently detected pathogen was SARS-CoV-2 ( n = 178; 47.2%) followed by RSV ( n = 109; 28.9%) and influenza A virus ( n = 74; 19.6%). ADV was detected in 10 (2.7%) and influenza B virus in six (1.6%) samples only. Participants with detection of influenza A virus reported more often cough (91%), fever (59.7%), and myalgia (43.3%) than participants with detection of RSV or SARS-CoV-2. The remaining 310 participants (21.7%) who had not developed ARI symptoms self-tested on June 1, 2023, yielding an RSV point prevalence of 7.1%.
Conclusion
This study allowed real-time reporting of five endemic ARI pathogens in a citizen science project. Symptom burden was highest in influenza A. Seasonal and off-seasonal RSV detection hint toward relevant RSV circulation in adults all year round.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Ger…
- Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
- German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
- Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Cologne, Germany.
- Medical School, University of Nicosia (UNIC), Nicosia, Cyprus.
Zitieren
APA
Nacov, J. A., Salmanton-García, J., Grimm, S., Stewart, F. A., Cremer, L. M., Rochel, L. M., Müller, E., Joisten, C., Többen, C., Mechtel, B., Fleig, J., Bethe, U., Mellinghoff, S. C., Pana, Z. D., Schmitt, H. J., Cornely, O. A., & Stemler, J. (2025). Self-testing for 5 respiratory viruses in adult VACCELERATE volunteers in Germany—a pilot study on multi-pathogen rapid antigen testing to monitor community-acquired acute respiratory infections. Frontiers in Public Health, 13. https://doi.org/10.3389/fpubh.2025.1638280
Vancouver
Nacov JA, Salmanton-García J, Grimm S, Stewart FA, Cremer LM, Rochel LM, et al. Self-testing for 5 respiratory viruses in adult VACCELERATE volunteers in Germany—a pilot study on multi-pathogen rapid antigen testing to monitor community-acquired acute respiratory infections. Frontiers in Public Health. 2025;13. doi:10.3389/fpubh.2025.1638280
BibTeX
@article{Nacov2025,
author = {Nacov, Julia A and Salmanton-García, Jon and Grimm, Sarah and Stewart, Fiona A and Cremer, Louise M and Rochel, Lisa Marie and Müller, Erik and Joisten, Carolin and Többen, Christina and Mechtel, Ben and Fleig, Julian and Bethe, Ullrich and Mellinghoff, Sibylle C and Pana, Zoi D and Schmitt, Heinz-Josef and Cornely, Oliver A and Stemler, Jannik},
title = {Self-testing for 5 respiratory viruses in adult VACCELERATE volunteers in Germany—a pilot study on multi-pathogen rapid antigen testing to monitor community-acquired acute respiratory infections},
journal = {Frontiers in Public Health},
year = {2025},
volume = {13},
doi = {10.3389/fpubh.2025.1638280}
}
EUVIMED